| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Rhs_assc_core | 3.61e-06 | 3 | 21 | 2 | IPR022385 | |
| Domain | Tox-GHH_dom | 7.21e-06 | 4 | 21 | 2 | IPR028916 | |
| Domain | TENEURIN_N | 7.21e-06 | 4 | 21 | 2 | PS51361 | |
| Domain | Ten_N | 7.21e-06 | 4 | 21 | 2 | IPR009471 | |
| Domain | Tox-GHH | 7.21e-06 | 4 | 21 | 2 | PF15636 | |
| Domain | Ten_N | 7.21e-06 | 4 | 21 | 2 | PF06484 | |
| Domain | YD | 1.20e-05 | 5 | 21 | 2 | IPR006530 | |
| Domain | CUT_dom | 2.52e-05 | 7 | 21 | 2 | IPR003350 | |
| Domain | CUT | 2.52e-05 | 7 | 21 | 2 | PF02376 | |
| Domain | CUT | 2.52e-05 | 7 | 21 | 2 | SM01109 | |
| Domain | CUT | 2.52e-05 | 7 | 21 | 2 | PS51042 | |
| Domain | NHL | 9.32e-05 | 13 | 21 | 2 | PS51125 | |
| Domain | CarboxyPept-like_regulatory | 1.62e-04 | 17 | 21 | 2 | IPR008969 | |
| Domain | Cupredoxin | 2.74e-04 | 22 | 21 | 2 | IPR008972 | |
| Domain | - | 4.16e-04 | 27 | 21 | 2 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 4.80e-04 | 29 | 21 | 2 | IPR010982 | |
| Domain | - | 8.70e-04 | 39 | 21 | 2 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.21e-03 | 46 | 21 | 2 | IPR011042 | |
| Domain | Homeobox_CS | 1.83e-02 | 186 | 21 | 2 | IPR017970 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 25059644 | ||
| Pubmed | Cux-1 and Cux-2 control the development of Reelin expressing cortical interneurons. | 5.80e-07 | 2 | 27 | 2 | 18327765 | |
| Pubmed | A unique variant of a homeobox gene related to Drosophila cut is expressed in mouse testis. | 5.80e-07 | 2 | 27 | 2 | 8879483 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 35581205 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26804994 | ||
| Pubmed | Expression of a cut-related homeobox gene in developing and polycystic mouse kidney. | 5.80e-07 | 2 | 27 | 2 | 8840273 | |
| Pubmed | The complete 685-kilobase DNA sequence of the human beta T cell receptor locus. | 8.74e-07 | 95 | 27 | 4 | 8650574 | |
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 3.48e-06 | 4 | 27 | 2 | 12000766 | |
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 3.48e-06 | 4 | 27 | 2 | 10225957 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 15656993 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 20510857 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 8798433 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 7910552 | ||
| Pubmed | 8.69e-06 | 6 | 27 | 2 | 15452856 | ||
| Pubmed | 1.22e-05 | 7 | 27 | 2 | 10625539 | ||
| Pubmed | 1.22e-05 | 7 | 27 | 2 | 12915301 | ||
| Pubmed | 1.62e-05 | 8 | 27 | 2 | 10331952 | ||
| Pubmed | 1.62e-05 | 8 | 27 | 2 | 21104742 | ||
| Pubmed | Ulk4, a Newly Discovered Susceptibility Gene for Schizophrenia, Regulates Corticogenesis in Mice. | 2.08e-05 | 9 | 27 | 2 | 34235142 | |
| Pubmed | 2.08e-05 | 9 | 27 | 2 | 31541646 | ||
| Pubmed | 2.60e-05 | 10 | 27 | 2 | 18033766 | ||
| Pubmed | IRX3/5 regulate mitotic chromatid segregation and limb bud shape. | 2.60e-05 | 10 | 27 | 2 | 32907847 | |
| Pubmed | Glycine receptors control the generation of projection neurons in the developing cerebral cortex. | 2.60e-05 | 10 | 27 | 2 | 24926615 | |
| Pubmed | 2.60e-05 | 10 | 27 | 2 | 38713721 | ||
| Pubmed | The genomic structure of human V beta 6 T cell antigen receptor genes. | 3.18e-05 | 11 | 27 | 2 | 1660526 | |
| Pubmed | 5.25e-05 | 14 | 27 | 2 | 17182777 | ||
| Pubmed | 5.25e-05 | 14 | 27 | 2 | 21965613 | ||
| Pubmed | Mllt11 Regulates Migration and Neurite Outgrowth of Cortical Projection Neurons during Development. | 6.92e-05 | 16 | 27 | 2 | 35379703 | |
| Pubmed | 6.92e-05 | 16 | 27 | 2 | 26235615 | ||
| Pubmed | 7.84e-05 | 17 | 27 | 2 | 21315259 | ||
| Pubmed | 9.84e-05 | 19 | 27 | 2 | 33597191 | ||
| Pubmed | 9.84e-05 | 19 | 27 | 2 | 21666133 | ||
| Pubmed | 1.21e-04 | 21 | 27 | 2 | 24483844 | ||
| Pubmed | 1.33e-04 | 22 | 27 | 2 | 20506362 | ||
| Pubmed | 1.45e-04 | 23 | 27 | 2 | 22090492 | ||
| Pubmed | 1.45e-04 | 23 | 27 | 2 | 30329130 | ||
| Pubmed | Multiple knockout mouse models reveal lincRNAs are required for life and brain development. | 1.59e-04 | 24 | 27 | 2 | 24381249 | |
| Pubmed | 1.59e-04 | 24 | 27 | 2 | 24931612 | ||
| Pubmed | 1.72e-04 | 25 | 27 | 2 | 28288114 | ||
| Pubmed | 1.72e-04 | 25 | 27 | 2 | 39271675 | ||
| Pubmed | 1.86e-04 | 26 | 27 | 2 | 19749747 | ||
| Pubmed | 2.01e-04 | 27 | 27 | 2 | 22334647 | ||
| Pubmed | Chromatin regulation by BAF170 controls cerebral cortical size and thickness. | 2.17e-04 | 28 | 27 | 2 | 23643363 | |
| Pubmed | 2.17e-04 | 28 | 27 | 2 | 18794345 | ||
| Pubmed | Genetic interplay between the transcription factors Sp8 and Emx2 in the patterning of the forebrain. | 2.49e-04 | 30 | 27 | 2 | 17470284 | |
| Pubmed | 2.84e-04 | 32 | 27 | 2 | 19571125 | ||
| Pubmed | Histone Deacetylase 3 Governs Perinatal Cerebral Development via Neural Stem and Progenitor Cells. | 3.21e-04 | 34 | 27 | 2 | 31569049 | |
| Pubmed | 3.40e-04 | 35 | 27 | 2 | 22991445 | ||
| Pubmed | 3.65e-04 | 814 | 27 | 5 | 23251661 | ||
| Pubmed | 4.01e-04 | 38 | 27 | 2 | 31080058 | ||
| Pubmed | 4.90e-04 | 42 | 27 | 2 | 24997765 | ||
| Pubmed | A cascade of morphogenic signaling initiated by the meninges controls corpus callosum formation. | 6.95e-04 | 50 | 27 | 2 | 22365545 | |
| Pubmed | 7.23e-04 | 51 | 27 | 2 | 16919471 | ||
| Cytoband | 7q34 | 2.78e-06 | 167 | 27 | 4 | 7q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q34 | 1.75e-04 | 185 | 27 | 3 | chr7q34 | |
| GeneFamily | T cell receptor beta locus at 7q34 | 1.45e-06 | 87 | 18 | 4 | 372 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 3.36e-05 | 9 | 18 | 2 | 527 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.14e-06 | 181 | 27 | 4 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 160 | 27 | 3 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 160 | 27 | 3 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 160 | 27 | 3 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.28e-04 | 163 | 27 | 3 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.28e-04 | 163 | 27 | 3 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | Mild-MAIT|World / Disease group and Cell class | 1.30e-04 | 164 | 27 | 3 | 21dc02997dfae73cf70ce291661928526605dba1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.38e-04 | 167 | 27 | 3 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 1.38e-04 | 167 | 27 | 3 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 169 | 27 | 3 | 7962165cab84af73d20b56eb70b1ed87c94025ef | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 173 | 27 | 3 | a042f78a4c69fcc6b5ca76e9bf01e34cee54c81c | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 173 | 27 | 3 | ca3d2a9562734f76127e3e7d54c10b63e95141bb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 173 | 27 | 3 | 19a9e10885173d7712996be8660a3a5a7a9aa39f | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 173 | 27 | 3 | 3c51e7bda1835c25915e50c801b0d643979971a3 | |
| ToppCell | critical-Myeloid-pDC|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.53e-04 | 173 | 27 | 3 | e8508c3efbe0f0fae51484a5535d43103c810d4e | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.58e-04 | 175 | 27 | 3 | 7f74961436f88c0e380819095e6104489914d765 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 175 | 27 | 3 | 21bc0e59a9509d38751ce6aad2325f341bc70eff | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.58e-04 | 175 | 27 | 3 | bee8f31f036dfcf9fc6ed29156554771a9ee3c60 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-04 | 176 | 27 | 3 | ac83a6cd4bcbb9ca1fc02a9fbd9d9629ef1df8ca | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_THTPA|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-04 | 176 | 27 | 3 | e788c7e0b2bfde31fddbf9e04d07140f8b964857 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_THTPA|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-04 | 178 | 27 | 3 | e4e11e4940c911c17806200c25096928153c684d | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 178 | 27 | 3 | 742ee0cb8cb585a5e34bd5b20aebe9bb99756e0c | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 179 | 27 | 3 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 180 | 27 | 3 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 180 | 27 | 3 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 180 | 27 | 3 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 182 | 27 | 3 | b8be66a867ea1bbae0820b26dbd55b68611f5ad5 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 182 | 27 | 3 | cb488f9a9b200e2557335ccf22535cd247512cdc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-04 | 184 | 27 | 3 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-04 | 184 | 27 | 3 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-04 | 190 | 27 | 3 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.01e-04 | 190 | 27 | 3 | f85cdd79eefd699ada7a91bf4997cc730a9b9846 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.04e-04 | 191 | 27 | 3 | fca19f2719806f3dc2dd2add7252ab1198548f4d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.04e-04 | 191 | 27 | 3 | 208cd307826b5af89f8f10c0c915f90f80a25c6c | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 192 | 27 | 3 | ec1fd2fb6e71f87189d66261909a84e2be63cacb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.08e-04 | 192 | 27 | 3 | ec279980602292fc8ed6362edd36a5c772d59777 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-04 | 192 | 27 | 3 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 2.11e-04 | 193 | 27 | 3 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.11e-04 | 193 | 27 | 3 | 43ffa8ecc72bebcd204279db2bde98ae48d97f90 | |
| ToppCell | severe-Plasmablast|World / disease stage, cell group and cell class | 2.14e-04 | 194 | 27 | 3 | 49e8f90db571a89b8a26aef31fcacd66429fed11 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-04 | 194 | 27 | 3 | 297286c57d7ee6338d9cf77b27eb2809378ce15d | |
| ToppCell | severe-Plasmablast|severe / disease stage, cell group and cell class | 2.17e-04 | 195 | 27 | 3 | e11616ad568e50e4c720b50b0c071f484c31d16b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-04 | 195 | 27 | 3 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | Mild/Remission-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.17e-04 | 195 | 27 | 3 | 52bdd609253613b7db75dccbc1c01c05e8d73f79 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 2.20e-04 | 196 | 27 | 3 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | Mild/Remission-Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.20e-04 | 196 | 27 | 3 | dcf0a804a79a05454658498d1f87320c7e079219 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 198 | 27 | 3 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 200 | 27 | 3 | 69295705fc614c2687f2b6c8e6aa0c6717841008 | |
| Drug | rhenium sulfide | 5.34e-06 | 4 | 22 | 2 | CID000159414 | |
| Drug | dimethylphenylphosphine | 8.90e-06 | 5 | 22 | 2 | CID000069597 | |
| Drug | covellite | 1.87e-05 | 7 | 22 | 2 | CID000014831 | |
| Drug | AC1L85AO | 3.44e-05 | 66 | 22 | 3 | CID000372705 | |
| Drug | AC1O52TI | 9.29e-05 | 15 | 22 | 2 | CID006426890 | |
| Drug | 5-iodouracil | 5.50e-04 | 36 | 22 | 2 | CID000069672 | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 7.37e-04 | 186 | 22 | 3 | 6198_DN | |
| Drug | Zardaverine [101975-10-4]; Up 200; 15uM; PC3; HT_HG-U133A | 7.48e-04 | 187 | 22 | 3 | 4209_UP | |
| Drug | ATP,Gamma S | 7.72e-04 | 189 | 22 | 3 | CID000002028 | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; HL60; HT_HG-U133A | 7.84e-04 | 190 | 22 | 3 | 1343_DN | |
| Drug | Homosalate [118-56-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 4355_UP | |
| Drug | Sulindac [38194-50-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 5528_UP | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 5680_UP | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; HL60; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 2579_DN | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 2235_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; PC3; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 4284_UP | |
| Drug | Glyburide | 1.43e-03 | 58 | 22 | 2 | ctd:D005905 | |
| Drug | Pyrrolizidine Alkaloids | 1.84e-03 | 66 | 22 | 2 | ctd:D011763 | |
| Disease | hematologic cancer (implicated_via_orthology) | 4.12e-05 | 13 | 22 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.96e-04 | 153 | 22 | 3 | EFO_0004611, EFO_0020944 | |
| Disease | response to simvastatin, myopathy | 4.28e-04 | 41 | 22 | 2 | EFO_0004145, GO_1903491 | |
| Disease | Tourette syndrome | 6.36e-04 | 50 | 22 | 2 | EFO_0004895 | |
| Disease | blood copper measurement | 6.36e-04 | 50 | 22 | 2 | EFO_0007578 | |
| Disease | cancer (implicated_via_orthology) | 1.00e-03 | 268 | 22 | 3 | DOID:162 (implicated_via_orthology) | |
| Disease | Cleft palate, cleft lip | 1.13e-03 | 279 | 22 | 3 | EFO_0003959, HP_0000175 | |
| Disease | Endometrial Carcinoma | 1.31e-03 | 72 | 22 | 2 | C0476089 | |
| Disease | free androgen index | 2.60e-03 | 374 | 22 | 3 | EFO_0007005 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 2.67e-03 | 801 | 22 | 4 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MNHNYMYWYRQDPGM | 46 | A0A0A6YYG2 | |
| VMRMDYMVYFSFLTW | 171 | P0DMS8 | |
| FYKSMASMMVQVWFA | 1001 | O60423 | |
| MAANVGSMFQYWKRF | 1 | O14529 | |
| NDMWLMMRKAYKYAF | 116 | Q96EU7 | |
| TPCNFMYKFWSGMYN | 491 | Q9Y216 | |
| MAANVGSMFQYWKRF | 1 | Q13948 | |
| NDVWNFKMTGRYEMY | 351 | Q9UBR1 | |
| MMQFAWQSYKRYAMG | 181 | Q9NR34 | |
| MLWWQQMYAHQYYMQ | 191 | Q9BSE4 | |
| KMLMVYFDYMRSWIQ | 696 | Q9Y6R4 | |
| EYKHSFKQTWMNNMM | 206 | Q02880 | |
| MMYSGEMCYWGSKYC | 211 | A6NDU8 | |
| MNKWRLYYQVLNFGM | 1 | P0C7V7 | |
| KEVQYEMFRSLMYWM | 2161 | Q9NT68 | |
| EMFRSLMYWMTVQYD | 2166 | Q9NT68 | |
| SGSYMWIYVFMGNML | 166 | Q9Y6L6 | |
| MNHEYMYWYRQDPGM | 46 | A0A0J9YXY3 | |
| FYWAMMYEYADVNML | 276 | Q5GH73 | |
| LQPNMYGMMEQWDKY | 116 | H3BPM6 | |
| MNHEYMYWYRQDPGM | 46 | P0DPF7 | |
| MLGLMYVYWTQLNMF | 586 | P04844 | |
| MWRYYNFARMRKMAD | 176 | Q8WW62 | |
| SLMYWMTVQYDNMGR | 2161 | Q6N022 | |
| WQSYQCFGMEYAMMV | 3756 | Q86WI1 | |
| MNHNSMYWYRQDPGM | 46 | A0A0K0K1D8 | |
| MEWFNNYKRSLATYM | 111 | Q14691 | |
| RAQMAMYFWEMGSNA | 571 | Q8TD43 |